Heritage Cannabis Investor Dashboard

Company Overview:

The Company is focused on becoming a vertically integrated cannabis provider that currently has two Health Canada approved licenced producers, through its subsidiaries Voyage Cannabis Corp. and CannaCure Corp. both regulated under the Cannabis Act Regulations. Working under these two licences, Heritage has two additional subsidiaries, Purefarma Solutions, which provides extraction services, and BriteLife Sciences which is focused on cannabis based medical solutions. Heritage as the parent company, is focused on providing the resources for its subsidiaries to advance their products or services to compete both domestically and internationally.

[stock_market_chart symbol=”CANN.CN” range=”1y” settings='{“primaryChartType”:”smoothedLine”,”width”:”100%”,”height”:”350px”,”marginTop”:0,”marginBottom”:0,”marginLeft”:10,”marginRight”:10,”primaryPanelTitle”:”Price”,”secondaryPanelTitle”:”Volume”,”fontSize”:13,”color”:”#383838″,”primaryLineColor”:”#000″,”primaryLineColorAlpha”:0.15,”secondaryLineColor”:”#000″,”secondaryLineColorAlpha”:0.15,”backgroundColor”:”#fff”,”gridColor”:”#e0e0e0″,”gridAlpha”:0.8,”cursorColor”:”#ba0000″,”cursorAlpha”:0.8,”scrollbarBackgroundColor”:”#fff”,”scrollbarSelectedBackgroundColor”:”#000″,”scrollbarGraphFillColor”:”#000″,”scrollbarSelectedGraphFillColor”:”#000″,”primaryLineThickness”:0,”secondaryLineThickness”:0,”gridThickness”:0,”precision”:2,”thousandsSeparator”:”,”,”decimalSeparator”:”.”,”usePrefixes”:false,”mouseWheelZoomEnabled”:false,”cursorEnabled”:false,”exportEnabled”:false,”scrollbarEnabled”:false,”legendEnabled”:false,”periods”:”1W,1M,6M,YTD,1Y,ALL”,”defaultPeriod”:”1y”}’]

Key Share Information:

Current Share Price$0.14
Market Capitalization (in Millions)$52.63
Last Quarter (Share Data)1/31/2019
Shares Outstanding (in Millions)375.92
Options (in Millions)12.18
Warrants (in Millions)1.92
Fully Diluted (in Millions)390.01
Enterprise Value$55.37
TTM Revenue$0.00
TTM Growth Margin %n/a
TTM Operating Expensesn/a
TTM OCF-$3.30
P/S TTMn/a
P/S (Last Quarter Run Rate)n/a

Key Balance Sheet Information (in Millions $CAD):

 CYQ4'16CYQ1'17CYQ2'17CYQ3'17CYQ4'17CYQ1'18CYQ2'18CYQ3'18CYQ4'18CYQ1'19
Cash$0.09$0.04$0.13$0.31$1.65$2.84$2.08$0.61$1.17$1.02
Biological Assets
Inventory$0.00
Total Assets$0.76$0.71$1.24$1.37$8.08$10.11$11.45$11.55$12.70$60.07
Net Tangible Assets$0.76$0.71$1.24$1.37$3.01$5.04$6.39$6.48$7.63-$17.96
Intangibles/Goodwill$5.07$5.07$5.07$5.07$5.07$78.03
Total Liabilities$0.40$0.39$0.37$0.34$0.40$0.55$0.83$1.10$0.71$3.76

Key Operating Items (Quarterly in Millions $CAD):

 CYQ4'16CYQ1'17CYQ2'17CYQ3'17CYQ4'17CYQ1'18CYQ2'18CYQ3'18CYQ4'18CYQ1'19
Revenue
Change in Fair Value of Biologial Assets
Gross Margin
Marketing and Sales
Investor Relations$0.07$0.04$0.04$0.02$0.11$0.01$0.01$0.03$0.16$0.10
Total Operating Expenses$1.02$0.11$0.74$0.46-$2.05-$1.94-$1.80-$1.74-$6.83$3.61
Operating Cash Flow (Quarterly)-$0.05-$0.61-$0.04-$0.42-$0.61-$0.02-$0.37-$1.22-$1.69
Investing Cash Flow (Quarterly)-$0.03-$0.04-$0.22-$0.91-$0.43-$1.91-$1.71-$0.53-$5.34
Financing Cash Flow (Quarterly)$0.04$0.74$0.44$2.67$2.23$1.17-$7.42$10.34$6.87

Listing Statement

All of the information on this dashboard was collected on a best efforts basis. This information should not be relied upon to make investment decisions. Always do your own diligence when purchasing a security and contact a licensed financial representative.

Share
Tweet
Share